Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 11;23(1):18.
doi: 10.1186/s13075-020-02401-x.

Impact of baseline clinical and radiological features on outcome of chronic rhinosinusitis in granulomatosis with polyangiitis

Affiliations

Impact of baseline clinical and radiological features on outcome of chronic rhinosinusitis in granulomatosis with polyangiitis

Sigrun Skaar Holme et al. Arthritis Res Ther. .

Abstract

Background: Granulomatosis with polyangiitis (GPA) causes a recurring inflammation in nose and paranasal sinuses that clinically resembles chronic rhinosinusitis (CRS) of other aetiologies. While sinonasal inflammation is not among the life-threatening features of GPA, patients report it to have major negative impact on quality of life. A relatively large proportion of GPA patients have severe CRS with extensive damage to nose and sinus structures evident by CT, but risk factors for severe CRS development remain largely unknown. In this study, we aimed to identify clinical and radiological predictors of CRS-related damage in GPA.

Methods: We included GPA patients who had clinical data sets from time of diagnosis, and two or more paranasal sinus CT scans obtained ≥12 months apart available for analysis. We defined time from first to last CT as the study observation period, and evaluated CRS development across this period using CT scores for inflammatory sinus bone thickening (osteitis), bone destructions, and sinus opacifications (here defined as mucosal disease). In logistic regression, we applied osteitis as main outcome measure for CRS-related damage.

Results: We evaluated 697 CT scans obtained over median 5 years observation from 116 GPA patients. We found that 39% (45/116) of the GPA patients remained free from CRS damage across the study observation period, while 33% (38/116) had progressive damage. By end of observation, 32% (37/116) of the GPA patients had developed severe osteitis. We identified mucosal disease at baseline as a predictor for osteitis (odds ratio 1.33), and we found that renal involvement at baseline was less common in patients with severe osteitis at last CT (41%, 15/37) than in patients with no osteitis (60%, 27/45).

Conclusions: In this largely unselected GPA patient cohort, baseline sinus mucosal disease associated with CRS-related damage, as measured by osteitis at the end of follow-up. We found no significant association with clinical factors, but the data set indicated an inverse relationship between renal involvement and severe sinonasal affliction.

Keywords: Chronic rhinosinusitis; Granulomatosis with polyangiitis; Inflammation; Osteitis; Paranasal sinuses; Saddle nose deformity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Plot showing the study timeline and osteitis development from baseline to end of follow-up. a Timeline plot. Timepoint zero was defined as the year of diagnosis. Median differences between the year of diagnosis and the time of the baseline and the last CT are shown as diamond-shaped points, and the interquartile ranges are shown as horizontal error bars. The mean study observation period with error bars of 2 standard deviations is shown at the bottom. b Groups of the study. At baseline, there were two groups. Three different osteitis trajectories ended in three different outcome groups. The connection lines show how the patients changed groups during the study observation period
Fig. 2
Fig. 2
The levels of the three CT parameters at baseline and last CT. Upper panel shows bone thickening (i.e. osteitis) measured by Global Osteitis Scoring Scale (GOSS), number of destructed sinonasal bone structures in the middle panel, and sinonasal mucosal disease measured by the Lund-Mackay score (LM-score) in the bottom panel. The variables are grouped by the degree of osteitis severity at last CT. The observations are shown as red dots
Fig. 3
Fig. 3
Associations to the degree of osteitis severity at last CT. Demographic data including age at diagnosis (a), baseline clinical data (b), and total sinus surgery (c). Limited/severe disease is by the definition of the WGET research group

Similar articles

Cited by

  • Rhinosinusitis: Evidence and experience - 2024.
    Romano FR, Anselmo-Lima WT, Kosugi EM, Sakano E, Valera FCP, Lessa M, Roithmann R, Pignatari S, Felippu AWD, Meotti CD, Barreto CC, Solé D, Goudouris ES, Kuschnir FC, Pinna FR, Serpa FS, Matsumoto GRLL, Freire GSM, Mello JF Junior, Boechat JL, Balsalobre Filho LL, Miyake MM, Nakanishi M, Fornazieri MA, Toro MDC, Tepedino MS, Rubini NPM, Mion OG, Dolci RLL, Voegels RL, Guimarães RE, Dortas SD Junior, Bezerra TFP, Dinarte VRP, Tamashiro E, Piltcher OB. Romano FR, et al. Braz J Otorhinolaryngol. 2025 May 19;91(5):101595. doi: 10.1016/j.bjorl.2025.101595. Online ahead of print. Braz J Otorhinolaryngol. 2025. PMID: 40398368 Free PMC article.
  • The Nasal Microbiome in ANCA-Associated Vasculitis: Picking the Nose for Clues on Disease Pathogenesis.
    Dekkema GJ, Rutgers A, Sanders JS, Stegeman CA, Heeringa P. Dekkema GJ, et al. Curr Rheumatol Rep. 2021 Jul 1;23(7):54. doi: 10.1007/s11926-021-01015-9. Curr Rheumatol Rep. 2021. PMID: 34196846 Free PMC article. Review.

References

    1. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Arthritis Rheum. 1994;37(2):187–92. - PubMed
    1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 Revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11. - PubMed
    1. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum. 1990;33(8):1101–7. - PubMed
    1. Holle JU, Gross WL, Latza U, NÖlle B, Ambrosch P, Heller M, Fertmann R, Reinhold–Keller E. Improved outcome in 445 patients with Wegener’s granulomatosis in a German vasculitis center over four decades. Arthritis & Rheum. 2011;63(1):257–66. - PubMed
    1. Puéchal X, Pagnoux C, Perrodeau É. Hamidou M, Boffa JJ, Kyndt X, Lifermann F, Papo T, Merrien D, Smail A, Delaval P. Long-term outcomes among participants in the WEGENT trial of remission-maintenance therapy for granulomatosis with polyangiitis (Wegener’s) or microscopic polyangiitis. Arthritis Rheumatol. 2016;68(3):690–701. - PubMed

Publication types

MeSH terms